Form 8-K - Current report:
SEC Accession No. 0001193125-22-256102
Filing Date
2022-10-03
Accepted
2022-10-03 07:00:35
Documents
16
Period of Report
2022-09-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d378570d8k.htm   iXBRL 8-K 34173
2 EX-10.1 d378570dex101.htm EX-10.1 152339
3 EX-10.2 d378570dex102.htm EX-10.2 184510
4 EX-99.1 d378570dex991.htm EX-99.1 8850
8 GRAPHIC g378570g1001212918109.jpg GRAPHIC 3881
  Complete submission text file 0001193125-22-256102.txt   611975

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA txmd-20220930.xsd EX-101.SCH 2878
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE txmd-20220930_lab.xml EX-101.LAB 17995
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txmd-20220930_pre.xml EX-101.PRE 11276
10 EXTRACTED XBRL INSTANCE DOCUMENT d378570d8k_htm.xml XML 3347
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 221285912
SIC: 2834 Pharmaceutical Preparations